Archives for March 1, 2018

← 2018

SCOPE 2018

A CRO monopoly? Sponsors frustrated with lack of options

By Melissa Fassbender

With fewer global mid-sized contract research organizations (CRO) through consolidation, some stakeholders are expressing concern that the industry could become a monopoly – “we may be getting there,” one expert said.

WuXi STA to make oligonucleotides for Regulus

By Staff Reporter

Regulus Therapeutics has entered into an oligonucleotide synthesis collaboration with STA Pharmaceuticals for research and mid-scale non-GMP/cGMP manufacturing.